Tricuspid Valve Regurgitation after Orthotopic Heart Transplantation: Prevalence and Etiology

Table 1

Patients demographics and characteristics.

		No TR/mild TR; 𝑛=140	≥mild-moderate TR; 𝑛=23	𝑃 value
Gender (% males)		82.8%	91.3%	NS
Age		50.0 ± 13.3	50.0 ± 12.6	NS
	ICM	52.9%	56.5%
Etiology	DCM	18.6%	21.7%	NS
	Other	28.6%	21.7%
Place of transplantation	Israel	59.3%	34.8%	0.028
Previous heart surgery		41.2%	35.3%	NS
Total ischemic time (minutes)		160.5 ± 52.1	170.8 ± 52.2	NS
Bypass time (minutes)		148.8 ± 34.2	150.0 ± 49.9	NS
Followup (years)		7.8 ± 4.6	10.5 ± 4.1	0.009

TR: tricuspid regurgitation; ICM: ischemic cardiomyopathy; DCM: dilated cardiomyopathy; NS: nonsignificant.